Compassionate use of a cell therapy for people with few options
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial gives people with serious diseases access to a special cell therapy (a treatment made from your own immune cells) when they have no other options. It's a 'compassionate use' program, meaning the drug is available outside of a clinical trial if you meet certain conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your doctor must ask for this treatment for you.
- You must have a serious or life-threatening illness and have no other good treatment options left.
- You cannot get into or continue in a clinical trial for your condition.
- You must be able to understand and accept the possible risks, with a real chance of benefit.
- This treatment cannot get in the way of ongoing or planned research studies.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment using specially modified immune cells (CAR-T cells) to fight certain blood cancers that have come back or haven't improved with standard treatments. It may help your body's own immune system attack the cancer cells.
This study looks at using tisagenlecleucel, a cell therapy, when the final product does not meet routine “commercial release” quality standards. It focuses on whether it can still be given safely and effectively to people with serious or life-threatening illness.
This trial provides access to a CAR T-cell therapy (ide-cel) that was made for you but didn't meet commercial release standards. It's an expanded access program for patients who have no other options and are stable enough to receive the treatment.
This program lets people with serious or life-threatening conditions get access to a medicine called ruxolitinib when they have no other good options and cannot join a clinical trial. It is a special access or compassionate use program, so your doctor must request it for you.
This trial tests a personalized cancer treatment called CAR-T therapy. It uses your own immune cells, which are modified in a lab to fight your specific type of blood cancer, and then given back to you. The goal is to see if this treatment is safe and feasible when produced locally.
This trial tests a new treatment using your own immune cells, called CAR-T cells, that are modified to find and attack lymphoma cells with CD20 or CD30 markers. It is for people whose lymphoma has not responded to standard treatments or has returned after treatment.
Hear when a new Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.